Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Rang in Aktien #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Aktienkurs
$0.00162013
Zuletzt synchronisiert: 2025-01-03
Marktkapitalisierung
$156.25K
Veränderung (1 Tag)
0.36%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Cyxone AB (publ) (CYXO)

Kategorie

Kursverlauf für Cyxone AB (publ) (CYXO)
Höchster Schlusskurs: $0.00 am 2025-01-01

Niedrigster Schlusskurs: $0.50 am 2016-06-01
Kursverlauf der Aktie von Cyxone AB (publ) von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 -8.09%
2024 -82.58%
2023 -77.33%
2022 -83.86%
2021 -39.25%
2020 12.33%
2019 61.54%
2018 -80.08%
2017 88.25%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE